This Week in Dermatology — May 29, 2026

Welcome to This Week in Dermatology. This week we're covering 4 notable papers spanning the systemic burden of severe skin diseases and recent advances in therapeutics. Let's dive in. First, we examine the significant systemic impact and mortality associated with severe dermatoses, with two papers this week offering crucial insights for bullous pemphigoid and severe cutaneous adverse reactions.

This week's papers:

1. Cardiac involvement in severe cutaneous adverse reactions: a Retrospective Observational Cohort Study of DRESS and SJS/TEN at a major Australian tertiary hospital.. Clin Exp Dermatol 2026
2. Increased Mortality in Patients with Bullous Pemphigoid: A Nationwide Population-based Cohort Study of 5,738 Patients in Sweden.. Acta Derm Venereol 2026
3. Long-Term Efficacy and Safety of Oleogel-S10 (Birch Triterpenes) for Pediatric Patients With Epidermolysis Bullosa.. Pediatr Dermatol 2026
4. Repeated switching between biosimilar ABP 654 and reference ustekinumab in patients with moderate-to-severe plaque psoriasis: a randomized, double-blinded clinical trial to support interchangeability.. Br J Dermatol 2026

Listen at AudioScholar